Induced pluripotent stem cells are cells derived from the skin or blood that have been reprogrammed back to an embryonic-like pluripotent state. This enables these cells to differentiate into various cell types and can be expanded indefinitely for therapeutic purposes.
The ground breaking work in this technology was discovered by the Japanese scientist Shinya Yamanaka and his team in 2006. They successfully reprogrammed somatic cells into induced pluripotent stem cells by transducing a specific set of genes such as Oct4, Sox2, c-Myc, and Klf4.
- Source Diversity: This refers to the ability to reprogram various types of mature cells (such as skin cells or blood cells) into pluripotent stem cells. This diversity is a critical advantage of iPSCs technology, providing a flexible range of options for cell material.
- Pluripotency: It indicates that the reprogrammed cells have diverse developmental potential. They can differentiate into various cell types needed within the patient’s body, including muscle cells, nerve cells, heart cells, and more. This makes them a powerful tool for researching and treating a variety of diseases.
- Self-Renewal Ability: iPSCs can continuously renew and differentiate themselves to produce new induced pluripotent stem cells, maintaining their stem cell status. This is crucial for long-term experiments and therapeutic applications as they can provide a sufficient quantity and quality of cells.
- Genetic Plasticity: Through the reprogramming process, induced pluripotent stem cells can be endowed engineered with specific genotypes and phenotypes. This means that scientists can adjust the characteristics of these cells, to make them more suitable for specific research or therapeutic needs.
- Ethical Controversy-Free: Induced pluripotent stem cells possess characteristics similar to embryonic stem cells, but without the ethical and moral controversies. Moreover, they can be generated using the individual’s own cells (autologous), eliminating disputes related to ethics and morality.
- Differentiation Potential: These cells exhibit extensive differentiation potential, capable of differentiating into all cell types within the body. Once differentiated into specific cell types, they acquire the complete functionality of those particular cells, enabling self-repair and the replacement of damaged tissues and cells.
- Unlimited Expansion: Induced pluripotent stem cells have the ability to self- renew, allowing for unlimited expansion. This means that once a small population of induced pluripotent stem cells is obtained, they can continuously proliferate in the laboratory, providing a sufficient quantity and quality of cells for research and therapeutic purposes.
Japan has granted conditional approval for the world’s first therapies derived from induced pluripotent stem cells (iPSCs), marking a major milestone in regenerative medicine. The treatments, developed for conditions such as heart failure and Parkinson’s disease, allow clinical use while further safety and efficacy data continue to be collected. This development highlights the growing potential of iPSC technology to transform the future of cell-based therapies.